A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
Safety and efficacy of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy for small-cell lung cancer: a retrospective, cohort-controlled trial | BMC Cancer | Full Text
Does Granulocyte Colony–Stimulating Factor Affect Survival in Patients with Advanced Non-small Cell Lung Cancer? - ScienceDirect
Lung cancer - The Lancet
Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer | NEJM
Overall survival and risk of second malignancies with cancer chemotherapy and G-CSF support - Annals of Oncology
Cancers | Free Full-Text | Primary Granulocyte Colony-Stimulating Factor Prophylaxis in Metastatic Pancreatic Cancer Patients Treated with FOLFIRINOX as the First-Line Treatment | HTML
Neutrophil-to-lymphocyte ratio is correlated to driver gene mutations in surgically-resected non-small cell lung cancer and its post-operative evolution impacts outcomes - Clinical Lung Cancer
Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy - Transplantation and Cellular Therapy, Official Publication of the ...
The effect of filgrastim or pegfilgrastim on survival outcomes of patients with cancer receiving myelosuppressive chemotherapy - Annals of Oncology
Granulocyte‐colony stimulating factor‐producing uterine cervical cancer treated with chemoradiotherapy: A case report with mutation analysis and literature review - Shiba - 2021 - Clinical Case Reports - Wiley Online Library
The role of granulocyte colony‑stimulating factor in breast cancer development: A review
Frontiers | G-CSF and G-CSFR Modulate CD4 and CD8 T Cell Responses to Promote Colon Tumor Growth and Are Potential Therapeutic Targets
The efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non‐small cell lung cancer - Sakaguchi - 2020 - Thoracic Cancer - Wiley Online Library
Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma | Journal for ImmunoTherapy of Cancer
The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer | Scientific Reports
Granulocyte Colony-Stimulating Factor Treatment During Radiotherapy Is Associated With Survival Benefit in Patients With Lung Ca
Systemic Treatment Options for Brain Metastases from Non–Small-Cell Lung Cancer
Cancers | Free Full-Text | A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis | HTML
Frontiers | GM-CSF: A Double-Edged Sword in Cancer Immunotherapy
Neutrophils, G‐CSF and their contribution to breast cancer metastasis - Mouchemore - 2018 - The FEBS Journal - Wiley Online Library
Safety of G-CSF with concurrent chemo-radiotherapy in limited-stage small cell lung cancer - Secondary analysis of the randomised phase 3 CONVERT trial - Lung Cancer
Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation Therapy - International Journal of Radiation Oncology,
Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative | BMC Pulmonary Medicine | Full
Who Benefits the Most From Adjuvant Durvalumab After Chemoradiotherapy for Non-small Cell Lung Cancer? An Exploratory Analysis - Practical Radiation Oncology
